ecently introduced its innovative medical
2019年3月28日 友達Cervilenz Inc. Maus said, “I am excited to join the Board as the commercial launch of CerviLenz gains momentum. Maus was a key contributor to management of company growth from 8 million to over 700 million during her ten plus career with Cytyc.Cervilenz Inc. Dedicated to making a difference in the world of prematurity, Cervilenz Inc. “Eileen’s background in reimbursement strategy and advocacy couldn’t come at a better time. Eileen Maus brings 20 years of experience in the life sciences industry as a senior sales and marketing executive. CerviLenz® measures cervical length to help obstetricians and midwives identify and manage pregnant women at high risk for preterm birth. It’s very rewarding to work with a company that is bringing a new device to market that will improve outcomes for moms and babies. recently introduced its innovative medical device to the obstetrics marketplace with great success. Michael Ross, and Dean Koch on the Board of Directors.
manufactures and markets CerviLenz® – an innovative, disposable medical device that measures cervical length to help identify and manage pregnant women at high risk for preterm birth.. Preterm birth is the leading cause of infant morbidity and mortality, affecting 12% of pregnancies in the United States.CLEVELAND, OH – June 21, 2011Cervilenz Inc. Maus was also Vice President, Commercial Operations, Surgical Division at Cytyc Corporation – a leader in biotech and women’s healthcare companies. Ms.”Ms. Maus built and managed sales forces for 5 new product launches, including the ThinPrep® Pap Test. “As we take the next steps to expand the market launch of CerviLenz, Eileen’s expertise in the commercialization of women’s health products will be especially valuable,” said George Dunbar, Executive Chairman of the Board. announced today the addition of a new member to its Board of Directors. We are thrilled that Eileen has joined the Board. https://www.nbbiaoda.com/ In addition to participating in the diligence of diagnostic companies for potential acquisition, she is developing a revolutionary laboratory technology. Maus is currently Chief Commercial Officer of Constitutional Medical Investors, a portfolio company of Warburg Pincus.” Ms. Also at Cytyc, Ms.
Main StreetSuite 300Chagrin Falls, OH 44022This release was published on openPR. Ms. Maus joins Tim Peterson and George Dunbar of Arboretum Ventures, Koleman Karleski of Chrysalis Ventures, Dr. Ms. donates a portion of revenue to charitableCervilenz Inc. # # #About Cervilenz Inc.100 N. Her leadership roles ranged from market research to strategic planning and reimbursement
manufactures and markets CerviLenz® – an innovative, disposable medical device that measures cervical length to help identify and manage pregnant women at high risk for preterm birth.. Preterm birth is the leading cause of infant morbidity and mortality, affecting 12% of pregnancies in the United States.CLEVELAND, OH – June 21, 2011Cervilenz Inc. Maus was also Vice President, Commercial Operations, Surgical Division at Cytyc Corporation – a leader in biotech and women’s healthcare companies. Ms.”Ms. Maus built and managed sales forces for 5 new product launches, including the ThinPrep® Pap Test. “As we take the next steps to expand the market launch of CerviLenz, Eileen’s expertise in the commercialization of women’s health products will be especially valuable,” said George Dunbar, Executive Chairman of the Board. announced today the addition of a new member to its Board of Directors. We are thrilled that Eileen has joined the Board. https://www.nbbiaoda.com/ In addition to participating in the diligence of diagnostic companies for potential acquisition, she is developing a revolutionary laboratory technology. Maus is currently Chief Commercial Officer of Constitutional Medical Investors, a portfolio company of Warburg Pincus.” Ms. Also at Cytyc, Ms.
Main StreetSuite 300Chagrin Falls, OH 44022This release was published on openPR. Ms. Maus joins Tim Peterson and George Dunbar of Arboretum Ventures, Koleman Karleski of Chrysalis Ventures, Dr. Ms. donates a portion of revenue to charitableCervilenz Inc. # # #About Cervilenz Inc.100 N. Her leadership roles ranged from market research to strategic planning and reimbursement
コメント